We have shown that Erk1/2 and Akt pathways were involved in prostratin-induced NPC proliferation and that both Erk1/2 and Akt are downstream effectors of prostratin-activated PKCs. This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.